Scott Reents

Scott Reents

Director of Finance/CFO at TOBIRA THERAPEUTICS INC

Net worth: 3 M $ as of 2024-03-30

57 year
Health Technology
Consumer Services

Profile

Scott T.
Reents
is currently the President & Director at Allergan, Inc. and Oculeve, Inc. He is also the Chief Financial Officer & Executive Vice President at AbbVie, Inc. and the Chief Financial Officer at Tobira Therapeutics, Inc. Previously, he worked as the Vice President-Tax at Abbott Laboratories.
Mr. Reents completed his undergraduate degree at the University of Nebraska and holds graduate and MBA degrees from the University of Washington.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-02-27 15,431 ( 0.00% ) 3 M $ 2024-03-30

Scott Reents active positions

CompaniesPositionStart
TOBIRA THERAPEUTICS INC Director of Finance/CFO -
ABBVIE INC. Director of Finance/CFO 2022-06-22
ALLERGAN, INC. President -
President -
All active positions of Scott Reents

Former positions of Scott Reents

CompaniesPositionEnd
ABBOTT LABORATORIES Comptroller/Controller/Auditor -
See the detail of Scott Reents's experience

Training of Scott Reents

University of Nebraska Undergraduate Degree
University of Washington Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott Reents's experience

Connections

87

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
ABBOTT LABORATORIES

Health Technology

ABBVIE INC.

Health Technology

Private companies3

Health Technology

Health Technology

Health Technology

See company connections